Company intelligence / Profile preview

Nexol

Incheon, South Korea

Ownership: Private
Development stage: Other

Overview

Nexol Co., Ltd. is a South Korean holding and investment company primarily known for its foundational role in the establishment of the Celltrion Group. Founded by Seo Jung-jin, the company served as the original vehicle for the creation of Celltrion, one of the world's leading biopharmaceutical companies specializing in biosimilars. While Nexol historically operated as the parent entity for various healthcare and biotech ventures, its primary significance today lies in its strategic ownership and historical legacy within the Korean life sciences ecosystem. The company continues to manage investments and strategic interests across the healthcare sector.

Industry: Investors

Partnerships

VaxGen (Historical partner for Celltrion establishment)

Beyond the preview

Go deeper on Nexol.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nexol.

Explore the full profile